Center for Scientific Review; Amended Notice of Meeting
---
identifier: "/us/fr/2020-05430"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Center for Scientific Review; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2020-05430"
section_name: "Center for Scientific Review; Amended Notice of Meeting"
positive_law: false
currency: "2020-03-17"
last_updated: "2020-03-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-05430"
document_type: "notice"
publication_date: "2020-03-17"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "85 FR 15207"
fr_volume: 85
---
# Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, Small Business: The Cancer Biotherapeutics Development (CBD), March 27, 2020 08:00 a.m. to March 27, 2020, 05:00 p.m., Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015, which was published in the *Federal Register* on March 4, 2020, 85 FR 12799.
The meeting location is being held at the National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. The meeting date and time remain the same.
Dated: March 11, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.